Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BGLC OTCMKTS:BICX OTCMKTS:CBAI OTCMKTS:TNTY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$4.37-0.9%$5.53$2.01▼$15.60$7.85M5.321.10 million shs25,684 shsBICXBiocorrx$0.45+56.0%$0.39$0.20▼$1.45$8.50M0.14338 shs3,500 shsCBAICBA Florida$0.01+1.3%$0.01$0.01▼$0.01$9.91MN/A2.73 million shs19.77 million shsTNTYTrue Nature$0.22-12.0%$0.21$0.02▼$0.11$19.05M2.99785,609 shs187,534 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab-11.27%-22.50%-20.83%+47.99%+15.75%BICXBiocorrx+56.01%-0.69%+9.67%+24.72%+49.67%CBAICBA Florida0.00%0.00%0.00%0.00%0.00%TNTYTrue Nature+85.32%+85.19%+73.91%-24.01%-13.79%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$4.37-0.9%$5.53$2.01▼$15.60$7.85M5.321.10 million shs25,684 shsBICXBiocorrx$0.45+56.0%$0.39$0.20▼$1.45$8.50M0.14338 shs3,500 shsCBAICBA Florida$0.01+1.3%$0.01$0.01▼$0.01$9.91MN/A2.73 million shs19.77 million shsTNTYTrue Nature$0.22-12.0%$0.21$0.02▼$0.11$19.05M2.99785,609 shs187,534 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab-11.27%-22.50%-20.83%+47.99%+15.75%BICXBiocorrx+56.01%-0.69%+9.67%+24.72%+49.67%CBAICBA Florida0.00%0.00%0.00%0.00%0.00%TNTYTrue Nature+85.32%+85.19%+73.91%-24.01%-13.79%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBGLCBioNexus Gene Lab 0.00N/AN/AN/ABICXBiocorrx 2.00HoldN/AN/ACBAICBA Florida 0.00N/AN/AN/ATNTYTrue Nature 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest TNTY, BGLC, CBAI, and BICX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/2/2025BICXBiocorrxZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBGLCBioNexus Gene Lab$9.55M0.82N/AN/A$4.63 per share0.94BICXBiocorrx$10K850.41N/AN/A($0.93) per share-0.48CBAICBA FloridaN/AN/AN/AN/AN/AN/ATNTYTrue NatureN/AN/AN/AN/A($0.03) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBGLCBioNexus Gene Lab-$1.60MN/A0.00∞N/A-30.70%-35.54%-29.08%N/ABICXBiocorrx-$5.11M-$0.35N/A∞N/AN/AN/A-130.26%11/13/2025 (Estimated)CBAICBA Florida-$40KN/A0.00∞N/AN/AN/AN/AN/ATNTYTrue Nature-$3.88MN/A0.00∞N/AN/AN/A-13,987.90%N/ALatest TNTY, BGLC, CBAI, and BICX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/18/2025Q2 2025BGLCBioNexus Gene LabN/A-$0.34N/A-$0.34N/A$2.26 million8/14/2025Q2 2025BICXBiocorrxN/A-$0.07N/A-$0.07N/A$0.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBGLCBioNexus Gene LabN/AN/AN/AN/AN/ABICXBiocorrxN/AN/AN/AN/AN/ACBAICBA FloridaN/AN/AN/AN/AN/ATNTYTrue NatureN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBGLCBioNexus Gene LabN/A3.632.94BICXBiocorrxN/A0.040.03CBAICBA FloridaN/AN/AN/ATNTYTrue NatureN/A0.040.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBGLCBioNexus Gene Lab18.85%BICXBiocorrxN/ACBAICBA FloridaN/ATNTYTrue NatureN/AInsider OwnershipCompanyInsider OwnershipBGLCBioNexus Gene Lab0.70%BICXBiocorrx21.40%CBAICBA Florida30.00%TNTYTrue Nature30.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBGLCBioNexus Gene Lab301.80 million1.78 millionNot OptionableBICXBiocorrx318.94 million14.88 millionNot OptionableCBAICBA Florida21.27 billion890.45 millionNot OptionableTNTYTrue Nature3086.57 millionN/ANot OptionableTNTY, BGLC, CBAI, and BICX HeadlinesRecent News About These CompaniesNature Unscripted – True 4K MomentsAugust 27, 2025 | msn.comTrue Moments of Nature in 4KAugust 17, 2025 | msn.comGiethoorn Village Walking Tour – Fairytale Canals in the Dutch CountrysideAugust 16, 2025 | msn.comIs “Animal Kingdom” based on a true story? Meet the real-life crime family that inspired the hit showJune 17, 2025 | msn.comTop 20 actors who hate being famousNovember 14, 2024 | soapcentral.comSResilience in the face of nature: An Oklahoma rancher's daily struggle with the elementsNovember 14, 2024 | ktul.comKWhy is Jake Paul vs Mike Tyson on Netflix? What fight means for future of live sportNovember 13, 2024 | msn.comChinese man cycles across the US to ‘show that human nature is good'November 9, 2024 | nbclosangeles.comNInter vs Arsenal LIVE: Champions League result and reaction as Hakan Calhanoglu penalty proves decisiveNovember 7, 2024 | msn.comThe Completely Free Nature Center Hiding in an Oklahoma State Park Is a Must-VisitNovember 6, 2024 | onlyinyourstate.comOSouth Carolina women's basketball bold predictions includes national tile, SEC MVP MiLaysia FulwileyNovember 4, 2024 | greenvilleonline.comGInvest in ethical hunting and recreation for the true balance of natureNovember 3, 2024 | durangoherald.comDAI in wrong hands can cause annihilation beyond imagination, says WHO AdvisorNovember 3, 2024 | msn.comGeorge Ford misses two last-gasp kicks in England’s agonising defeat by New ZealandNovember 3, 2024 | telegraph.co.ukWhat is a Conservative? Understanding how the term works in American politicsNovember 1, 2024 | thenewstribune.comTTrump heads West for back-to-back rallies, Harris campaigns with Obama and Springsteen as race tightensOctober 30, 2024 | cbsnews.comKyrie Irving's expertise in key area shows why he's perfect for MavericksOctober 30, 2024 | msn.comThe best shows on Peacock right now (November 2024)October 30, 2024 | msn.comJulia Leigh’s The Hunter at 25: a ruthlessly unsentimental tale of nature betrayedOctober 29, 2024 | theconversation.comT10 Smallest Motorcycles You Can Buy In 2024October 27, 2024 | topspeed.comTNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTNTY, BGLC, CBAI, and BICX Company DescriptionsBioNexus Gene Lab NASDAQ:BGLC$4.37 -0.04 (-0.91%) Closing price 04:00 PM EasternExtended Trading$4.36 -0.01 (-0.23%) As of 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Biocorrx OTCMKTS:BICX$0.45 +0.16 (+56.01%) As of 09/9/2025 03:14 PM EasternBioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.CBA Florida OTCMKTS:CBAI$0.0078 +0.00 (+1.30%) As of 06/30/2020CBA Florida, Inc. does not have significant operations. Previously, the company provided private cord blood and cord tissue stem cell services. The company was formerly known as Cord Blood America, Inc. and changed its name to CBA Florida, Inc. in May 2018. CBA Florida, Inc. is based in Las Vegas, Nevada.True Nature OTCMKTS:TNTY$0.22 -0.03 (-12.00%) As of 09/9/2025True Nature Holding, Inc. focuses on engaging in compounding pharmacy activities direct to consumers, doctors, and veterinary professionals. It also focuses on the development of software applications in the healthcare arena, including telemedicine; and consideration of services offering using blockchain encryption technology for various aspects of the healthcare industry. The company is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Celsius Stock Surges After Blowout Earnings and Pepsi Deal Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Alphabet Stock’s Weakness Was Wall Street’s Opportunity Should You Buy Figma Stock After Its 55% Post-IPO Drop? Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead Forget QQQ: This ETF Marries the Magnificent 7 and Communications Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
